Main complications and results of treatment with intra‑arterial infusion chemotherapy through the subclavian and thoracic arteries for locally advanced breast cancer

Singletary SE, Allred C, Ashley P, et al: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 20:3628–3636. 2002. View Article : Google Scholar : PubMed/NCBI

Kaufmann M, von Minckwitz G, Bear HD, et al: Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol. 18:1927–1934. 2007. View Article : Google Scholar : PubMed/NCBI

Olson JE, Neuberg D, Pandya KJ, et al: The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer. 79:1138–1149. 1997. View Article : Google Scholar

Murakami M, Kuroda Y, Nishimura S, et al: Intraarterial infusion chemotherapy and radiotherapy with or without surgery for patients with locally advanced or recurrent breast cancer. Am J Clin Oncol. 24:185–191. 2001. View Article : Google Scholar : PubMed/NCBI

Kitagawa K, Yamakado K, Nakatsuka A, et al: Preoperative transcatheter arterial infusion chemotherapy for locally advanced breast cancer (stageIIIb) for down-staging and increase of respectability. Eur J Radiol. 43:31–36. 2002. View Article : Google Scholar

Fiorentini G, Tsetis D, Bernardeschi P, et al: First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer. Anticancer Res. 23:4339–4345. 2003.PubMed/NCBI

Pacetti P, Mambrini A, Paolucci R, et al: Intra-arterial chemotherapy: a safe treatment for elderly patients with locally advanced breast cancer. In Vivo. 20:761–764. 2006.PubMed/NCBI

Shimamoto H, Takizawa K, Ogawa Y, et al: Clinical efficacy and value of redistributed subclavian arterial infusion chemotherapy for locally advanced breast cancer. Jpn J Radiol. 29:236–243. 2011. View Article : Google Scholar : PubMed/NCBI

Shenkier T, Weir L, Levine M, et al: Steering committee on clinical practice guidelines for the care and treatment of breast cancer. Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CMAJ. 170:983–994. 2004. View Article : Google Scholar

Huang EH, Tucker SL, Strom EA, et al: Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 62:351–357. 2005. View Article : Google Scholar : PubMed/NCBI

Fisher B, Bryant J, Wolmark N, et al: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 16:2672–2685. 1998.PubMed/NCBI

Wolmark N, Wang J, Mamounas E, et al: Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National surgical adjuvant breast and bowel project B-18. J Natl Cancer Inst Monogr. 30:96–102. 2001.PubMed/NCBI

van der Hage JA, van de Velde CJ, Julien JP, et al: Preoperative chemotherapy in primary operable breast cancer: results from the European organization for Research and Treatment of Cancer trial 10902. J Clin Oncol. 19:4224–4237. 2001.

Mauriac L, MacGrogan G, Avril A, et al: Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month medial follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS). Ann Oncol. 10:47–52. 1999.PubMed/NCBI

Eniu A, Palmieri FM and Perez EA: Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer. Oncologist. 10:665–685. 2005. View Article : Google Scholar : PubMed/NCBI

Heller W, Mazhar D, Ward R, et al: Neoadjuvant 5-fluorouracil epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer. Oncol Rep. 17:253–259. 2007.